Show simple item record

APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer

dc.contributor.authorSøgaard, Caroline Danielsen
dc.contributor.authorMoestue, Siver Andreas
dc.contributor.authorRye, Morten Beck
dc.contributor.authorKim, Jana
dc.contributor.authorNepal, Anala
dc.contributor.authorLiabakk, Nina-Beate
dc.contributor.authorBachke, Siri
dc.contributor.authorBathen, Tone Frost
dc.contributor.authorOtterlei, Marit
dc.contributor.authorHill, Deborah Katherine
dc.date.accessioned2019-03-23T21:50:38Z
dc.date.available2019-03-23T21:50:38Z
dc.date.created2017-11-10T10:43:11Z
dc.date.issued2018
dc.identifier.citationSøgaard, C. D., Moestue, S. A., Rye, M. B., Kim, J., Nepal, A., Liabakk, N.-B., ... Hill, D. K. (2018). APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer. OncoTarget, 9(14), 11752-11766. doi:nb_NO
dc.identifier.issn1949-2553
dc.identifier.urihttp://hdl.handle.net/11250/2591427
dc.language.isoengnb_NO
dc.publisherImpact Journals LLCnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleAPIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancernb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.rights.holder© 2018, The Author(s)nb_NO
dc.subject.nsiVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762nb_NO
dc.source.pagenumber11752-11766nb_NO
dc.source.volume9nb_NO
dc.source.journalOncoTargetnb_NO
dc.source.issue14nb_NO
dc.identifier.doi10.18632/oncotarget.24357
dc.identifier.cristin1512870
dc.relation.projectNorges forskningsråd: 239940nb_NO


Files in this item

Thumbnail
Name:
Moestue.pdf
Size:
2.660Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal